[HTML][HTML] Engineering nanoparticles for targeted delivery of nucleic acid therapeutics in tumor
Y Xiao, K Shi, Y Qu, B Chu, Z Qian - Molecular Therapy Methods & Clinical …, 2019 - cell.com
In the past 10 years, with the increase of investment in clinical nano-gene therapy, there are
many trials that have been discontinued due to poor efficacy and serious side effects …
many trials that have been discontinued due to poor efficacy and serious side effects …
[HTML][HTML] Engineering Nanoparticles for Targeted Delivery of Nucleic Acid Therapeutics in Tumor
Y Xiao, K Shi, Y Qu, B Chu, Z Qian - Molecular Therapy-Methods & Clinical …, 2019 - Elsevier
In the past 10 years, with the increase of investment in clinical nano-gene therapy, there are
many trials that have been discontinued due to poor efficacy and serious side effects …
many trials that have been discontinued due to poor efficacy and serious side effects …
Engineering Nanoparticles for Targeted Delivery of Nucleic Acid Therapeutics in Tumor
X Yao, K Shi, Y Qu, B Chu… - … Therapy. Methods & …, 2019 - search.proquest.com
In the past 10 years, with the increase of investment in clinical nano-gene therapy, there are
many trials that have been discontinued due to poor efficacy and serious side effects …
many trials that have been discontinued due to poor efficacy and serious side effects …
[引用][C] Engineering Nanoparticles for Targeted Delivery of Nucleic Acid Therapeutics in Tumor
Y Xiao, K Shi, Y Qu, B Chu, Z Qian - Molecular Therapy-Methods & …, 2019 - cir.nii.ac.jp
Engineering Nanoparticles for Targeted Delivery of Nucleic Acid Therapeutics in Tumor |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォーム …
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォーム …
[HTML][HTML] Engineering Nanoparticles for Targeted Delivery of Nucleic Acid Therapeutics in Tumor
Y Xiao, K Shi, Y Qu, B Chu, Z Qian - Molecular Therapy. Methods & …, 2019 - ncbi.nlm.nih.gov
In the past 10 years, with the increase of investment in clinical nano-gene therapy, there are
many trials that have been discontinued due to poor efficacy and serious side effects …
many trials that have been discontinued due to poor efficacy and serious side effects …
Engineering Nanoparticles for Targeted Delivery of Nucleic Acid Therapeutics in Tumor.
Y Xiao, K Shi, Y Qu, B Chu, Z Qian - Molecular therapy. Methods & …, 2018 - europepmc.org
In the past 10 years, with the increase of investment in clinical nano-gene therapy, there are
many trials that have been discontinued due to poor efficacy and serious side effects …
many trials that have been discontinued due to poor efficacy and serious side effects …
Engineering Nanoparticles for Targeted Delivery of Nucleic Acid Therapeutics in Tumor
Y Xiao, K Shi, Y Qu, B Chu, Z Qian - cell.com
In the past 10 years, with the increase of investment in clinical nano-gene therapy, there are
many trials that have been discontinued due to poor efficacy and serious side effects …
many trials that have been discontinued due to poor efficacy and serious side effects …
Engineering Nanoparticles for Targeted Delivery of Nucleic Acid Therapeutics in Tumor
Y Xiao, K Shi, Y Qu, B Chu… - … therapy. Methods & …, 2018 - pubmed.ncbi.nlm.nih.gov
In the past 10 years, with the increase of investment in clinical nano-gene therapy, there are
many trials that have been discontinued due to poor efficacy and serious side effects …
many trials that have been discontinued due to poor efficacy and serious side effects …